CELU Live signaler | Maksimer profitt med Getagraph.com

KJøP 109593 min ago

@ $0.410

Utstedt: 12 feb 2024 @ 22:00

Avkastning: 636.59%

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases...

Stats
Dagens volum	48 969.00
Gjennomsnittsvolum	96 312.00
Markedsverdi	65.78M
EPS	$0 ( 2024-04-02 )
Neste inntjeningsdato	( $-0.140 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.290
ATR14	$0.0260 (0.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-13	Fletcher Kyle	Sell	20	Class A Common Stock
2024-04-13	Haines John R	Sell	576	Class A Common Stock
2024-04-13	Beers David C	Sell	360	Class A Common Stock
2024-04-13	Hariri Robert J	Sell	1 154	Class A Common Stock
2024-04-13	Brigido Stephen	Sell	268	Class A Common Stock

INSIDER POWER
57.06
Last 98 transactions
Buy: 89 262 897 \| Sell: 26 354 903

Volum Korrelasjon

Lang: -0.01 (neutral)

Kort: -0.26 (neutral)

Signal:(49.54) Neutral

Celularity Inc. Korrelasjon

10 Mest positive korrelasjoner
ASPS	0.945
AUID	0.931
CLFD	0.93
PROG	0.93
OP	0.927
AYLA	0.927
JUPW	0.925
PCSA	0.925
ADP	0.925
DWACU	0.923

10 Mest negative korrelasjoner
CBAY	-0.935
TIOA	-0.926
CITE	-0.922
FXCO	-0.917
BWC	-0.915
XPDB	-0.915
BRIV	-0.914
TIOAU	-0.914
ROCL	-0.914
ITAQ	-0.912

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Celularity Inc. Korrelasjon - Valuta/Råvare

0.21
( neutral )

0.39
( neutral )

0.00
( neutral )

0.53
( weak )

-0.18
( neutral )

-0.34
( neutral )

Celularity Inc. Økonomi

Annual	2022
Omsetning:	$17.98M
Bruttogevinst:	$-1.69M (-9.40 %)
EPS:	$1.010

FY	2022
Omsetning:	$17.98M
Bruttogevinst:	$-1.69M (-9.40 %)
EPS:	$1.010

FY	2021
Omsetning:	$21.34M
Bruttogevinst:	$17.69M (82.90 %)
EPS:	$-12.49

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0215

Financial Reports:

No articles found.

Celularity Inc.

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.